FJERZA, RAJMONDA
FJERZA, RAJMONDA
Medicina Sperimentale e Clinica
Abnormal expression patterns of WT1-as, MEG3 and ANRIL long non-coding RNAs in CD34+ cells from patients with primary myelofibrosis and their clinical correlations.
2015 Pennucci, V1; Zini, R; Norfo, R; Guglielmelli, Paola; Bianchi, E; Salati, S; Sacchi, G; Prudente, Z; Tenedini, E; Ruberti, S; Paoli, C; Fanelli, Tiziana; Mannarelli, C; Tagliafico, E; Ferrari, S; Vannucchi, Am; Manfredini, R; Bogani, C; Bosi, Alberto; Fanelli, T; Fjerza, Rajmonda; Guglielmelli, P.
Calreticulin Mutation Is Associated with Milder Disease in Patients with Post Essential Thrombocythemia Myelofibrosis (PET-MF) Compared with JAK2V617F Mutation: A Study from the AGIMM Group
2014 Guglielmelli, P; Rotunno, G; Brogi, G; Pacilli, A; Bogani, C; Mannarelli, C; Pancrazzi, A; Fjerza, R; Pieri, L; Rumi, E; Pietra, D; Salmoiraghi, S; Provenzano, A; Giunti, L; Giglio, S; Maffioli, M; Bosi, A; Rambaldi, A; Barbui, T; Passamonti, F; Cazzola, M; Vannucchi, Am
Calreticulin mutation-specific immunostaining in myeloproliferative neoplasms: Pathogenetic insight and diagnostic value
2014 Vannucchi, A.M.; Rotunno, G.; Bartalucci, N.; Raugei, G.; Carrai, V.; Balliu, M.; Mannarelli, C.; Pacilli, A.; Calabresi, L.; Fjerza, R.; Pieri, L.; Bosi, A.; Manfredini, R.; Guglielmelli, P.
Impact of JAK2(V617F) mutation status on treatment response to anagrelide in essential thrombocythemia: An observational, hypothesis-generating study
2015 Cascavilla, Nicola; De Stefano, Valerio; Pane, Fabrizio; Pancrazzi, Alessandro; Iurlo, Alessandra; Gobbi, Marco; Palandri, Francesca; Specchia, Giorgina; Marina Liberati, A.; D’Adda, Mariella; Gaidano, Gianluca; Fjerza, Rajmonda; Achenbach, Heinrich; Smith, Jonathan; Wilde, Paul; Vannucchi, Alessandro M.
JAK2V617F complete molecular remission in polycythemia vera/essential thrombocythemia patients treated with ruxolitinib
2015 Pieri, Lisa; Pancrazzi, Alessandro; Pacilli, Annalisa; Rabuzzi, Claudia; Rotunno, Giada; Fanelli, Tiziana; Guglielmelli, Paola; Fjerza, Rajmonda; Paoli, Chiara; Verstovsek, Srdan; Vannucchi, Alessandro M
Patients with ≥ 20 × 10(9)/L Platelets at Baseline May Have a Prompt Response to Romiplostim During the Early Phase of Treatment: an Italian Single-Institution Experience.
2012 Baldini, S; Rigacci, L; Carrai, Valentina; Alterini, R; Fjerza, Rajmonda; Bosi, Alberto
Prognostic impact of bone marrow fibrosis in primary myelofibrosis. A study of the AGIMM group on 490 patients
2016 Guglielmelli, Paola; Rotunno, Giada; Pacilli, Annalisa; Rumi, Elisa; Rosti, Vittorio; Delaini, Federica; Maffioli, Margherita; Fanelli, Tiziana; Pancrazzi, Alessandro; Pieri, Lisa; Fjerza, Rajmonda; Pietra, Daniela; Cilloni, Daniela; Sant'Antonio, Emanuela; Salmoiraghi, Silvia; Passamonti, Francesco; Rambaldi, Alessandro; Barosi, Giovanni; Barbui, Tiziano; Cazzola, Mario; Vannucchi, Alessandro M.
Safe and Successful Surgical Outcome in Persons with Hemophilia A with and without Inhibitors Treated with Emicizumab: A Large, Single Center, Real-World Experience
2023 Castaman, Giancarlo; Linari, Silvia; Pieri, Lisa; Carulli, Christian; Prosperi, Paolo; Tonelli, Paolo; Demartis, Francesco; Fjerza, Rajmonda; Attanasio, Monica; Coppo, Mirella; Salvianti, Francesca
Safety and efficacy of ruxolitinib in splanchnic vein thrombosis associated with myeloproliferative neoplasms
2017 Pieri, Lisa; Paoli, Chiara; Arena, Umberto; Marra, Fabio; Mori, Fabio; Zucchini, Mery; Colagrande, Stefano; Castellani, Alessandro; Masciulli, Arianna; Rosti, Vittorio; De Stefano, Valerio; Betti, Silvia; Finazzi, Guido; Ferrari, Maria Luisa; Rumi, Elisa; Ruggeri, Marco; Nichele, Ilaria; Guglielmelli, Paola; Fjerza, Rajmonda; Mannarelli, Carmela; Fanelli, Tiziana; Merli, Lucia; Corbizi Fattori, Giuditta; Massa, Margherita; Cimino, Giuseppe; Rambaldi, Alessandro; Barosi, Giovanni; Cazzola, Mario; Barbui, Tiziano; Vannucchi, Alessandro M.
Two case of Hermansky-Pudlak Syndrome associated with novel mutations in HPS3 and HPS6 genes.
2022 L. Pieri, M. Attanasio, M. Coppo, F. Salvianti, S. Linari, F. Demartis, R. Fjerza, CM.C. Di Stefano, G. Castaman
| Titolo | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|
| Abnormal expression patterns of WT1-as, MEG3 and ANRIL long non-coding RNAs in CD34+ cells from patients with primary myelofibrosis and their clinical correlations. | 2015 | Pennucci, V1; Zini, R; Norfo, R; Guglielmelli, Paola; Bianchi, E; Salati, S; Sacchi, G; Prudente, Z; Tenedini, E; Ruberti, S; Paoli, C; Fanelli, Tiziana; Mannarelli, C; Tagliafico, E; Ferrari, S; Vannucchi, Am; Manfredini, R; Bogani, C; Bosi, Alberto; Fanelli, T; Fjerza, Rajmonda; Guglielmelli, P. | |
| Calreticulin Mutation Is Associated with Milder Disease in Patients with Post Essential Thrombocythemia Myelofibrosis (PET-MF) Compared with JAK2V617F Mutation: A Study from the AGIMM Group | 2014 | Guglielmelli, P; Rotunno, G; Brogi, G; Pacilli, A; Bogani, C; Mannarelli, C; Pancrazzi, A; Fjerza, R; Pieri, L; Rumi, E; Pietra, D; Salmoiraghi, S; Provenzano, A; Giunti, L; Giglio, S; Maffioli, M; Bosi, A; Rambaldi, A; Barbui, T; Passamonti, F; Cazzola, M; Vannucchi, Am | |
| Calreticulin mutation-specific immunostaining in myeloproliferative neoplasms: Pathogenetic insight and diagnostic value | 2014 | Vannucchi, A.M.; Rotunno, G.; Bartalucci, N.; Raugei, G.; Carrai, V.; Balliu, M.; Mannarelli, C.; Pacilli, A.; Calabresi, L.; Fjerza, R.; Pieri, L.; Bosi, A.; Manfredini, R.; Guglielmelli, P. | |
| Impact of JAK2(V617F) mutation status on treatment response to anagrelide in essential thrombocythemia: An observational, hypothesis-generating study | 2015 | Cascavilla, Nicola; De Stefano, Valerio; Pane, Fabrizio; Pancrazzi, Alessandro; Iurlo, Alessandra; Gobbi, Marco; Palandri, Francesca; Specchia, Giorgina; Marina Liberati, A.; D’Adda, Mariella; Gaidano, Gianluca; Fjerza, Rajmonda; Achenbach, Heinrich; Smith, Jonathan; Wilde, Paul; Vannucchi, Alessandro M. | |
| JAK2V617F complete molecular remission in polycythemia vera/essential thrombocythemia patients treated with ruxolitinib | 2015 | Pieri, Lisa; Pancrazzi, Alessandro; Pacilli, Annalisa; Rabuzzi, Claudia; Rotunno, Giada; Fanelli, Tiziana; Guglielmelli, Paola; Fjerza, Rajmonda; Paoli, Chiara; Verstovsek, Srdan; Vannucchi, Alessandro M | |
| Patients with ≥ 20 × 10(9)/L Platelets at Baseline May Have a Prompt Response to Romiplostim During the Early Phase of Treatment: an Italian Single-Institution Experience. | 2012 | Baldini, S; Rigacci, L; Carrai, Valentina; Alterini, R; Fjerza, Rajmonda; Bosi, Alberto | |
| Prognostic impact of bone marrow fibrosis in primary myelofibrosis. A study of the AGIMM group on 490 patients | 2016 | Guglielmelli, Paola; Rotunno, Giada; Pacilli, Annalisa; Rumi, Elisa; Rosti, Vittorio; Delaini, Federica; Maffioli, Margherita; Fanelli, Tiziana; Pancrazzi, Alessandro; Pieri, Lisa; Fjerza, Rajmonda; Pietra, Daniela; Cilloni, Daniela; Sant'Antonio, Emanuela; Salmoiraghi, Silvia; Passamonti, Francesco; Rambaldi, Alessandro; Barosi, Giovanni; Barbui, Tiziano; Cazzola, Mario; Vannucchi, Alessandro M. | |
| Safe and Successful Surgical Outcome in Persons with Hemophilia A with and without Inhibitors Treated with Emicizumab: A Large, Single Center, Real-World Experience | 2023 | Castaman, Giancarlo; Linari, Silvia; Pieri, Lisa; Carulli, Christian; Prosperi, Paolo; Tonelli, Paolo; Demartis, Francesco; Fjerza, Rajmonda; Attanasio, Monica; Coppo, Mirella; Salvianti, Francesca | |
| Safety and efficacy of ruxolitinib in splanchnic vein thrombosis associated with myeloproliferative neoplasms | 2017 | Pieri, Lisa; Paoli, Chiara; Arena, Umberto; Marra, Fabio; Mori, Fabio; Zucchini, Mery; Colagrande, Stefano; Castellani, Alessandro; Masciulli, Arianna; Rosti, Vittorio; De Stefano, Valerio; Betti, Silvia; Finazzi, Guido; Ferrari, Maria Luisa; Rumi, Elisa; Ruggeri, Marco; Nichele, Ilaria; Guglielmelli, Paola; Fjerza, Rajmonda; Mannarelli, Carmela; Fanelli, Tiziana; Merli, Lucia; Corbizi Fattori, Giuditta; Massa, Margherita; Cimino, Giuseppe; Rambaldi, Alessandro; Barosi, Giovanni; Cazzola, Mario; Barbui, Tiziano; Vannucchi, Alessandro M. | |
| Two case of Hermansky-Pudlak Syndrome associated with novel mutations in HPS3 and HPS6 genes. | 2022 | L. Pieri, M. Attanasio, M. Coppo, F. Salvianti, S. Linari, F. Demartis, R. Fjerza, CM.C. Di Stefano, G. Castaman |